Search - tctmd.com

Displaying 21 - 40 of 106

Sort: Relevancy | Date

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

The STRENGTH Trial

Podcast TCTMD Talking Points

The STRENGTH Trial

June 02, 2021

New STRENGTH Analysis Revives Omega-3 Debate

News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

May 20, 2021

May 2021 News Roundup

News Opinion CV Team Dispatch

May 2021 News Roundup

May 01, 2021

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

News Daily News

VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear

March 17, 2021

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

News Daily News

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Michael O'Riordan

March 11, 2021

February 2021 News Roundup

News Opinion CV Team Dispatch

February 2021 News Roundup

February 01, 2021

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

November 15, 2020

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

News Conference News AHA 2020

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

November 15, 2020

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

News Conference News AHA 2020

Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm

November 13, 2020

More Circulating Omega-3s May Boost Prognosis After STEMI

News Daily News

More Circulating Omega-3s May Boost Prognosis After STEMI

October 26, 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

October 21, 2020

Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review

News Daily News

Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review

September 15, 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

News Daily News

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

August 11, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.